Figure 2. Classes of medication for the treatment of LUTs and site of action within the lower urinary tract; adapted from Sarma AV,Wei JT. Benign prostatic hyperplasia and lower urinary tract symptoms. N Engl J Med. 2012;367:248-57.
Background
Benign prostatic hyperplasia (BPH) is a...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.